GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: CEO Anders Lönner has increased its shareholding in Meda (STO:MEDAA) by the acquisition of 80 000 shares.
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in 120 countries worldwide and the company is represented by its own organizations in 50 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.
